TOP STORIES

• REGULATORY Chugai Hemophilia Drug, Novel Zoster Vaccine Set for Approval Review on March 2
  February 19, 2018

• REGULATORY 20 Gx Makers Flock to Aimix, Sawai Earns Approval for Tamiflu Copy for June Listing
  February 16, 2018

• BUSINESS Sumitomo Dainippon Sues 2 Gx Makers over Latuda, Delays New 5-Year-Plan Announcement
  February 15, 2018

• REGULATORY MHLW Looked at Balance and Made Major Revision Plans for Drug Pricing: Official
  February 14, 2018

• BUSINESS Pricing Revamp for Off-Patent Brands “Within Our Expectation”: LTL Pharma CEO
  February 13, 2018

• ORGANIZATION Private Univ. Group Encourages “Single-Product, Single-Price” Deals in Response to New Distribution GL, Tougher Medical Fee Cut Rules
  February 9, 2018

• TRENDS With 2 Players Closing in on Suglat, SGLT2 Inhibitors Entering Triangular Battle
  February 8, 2018

• REGULATORY Chuikyo Submits Recommendation for FY2018 Reimbursement Policy Reform, Drug Pricing Package Enshrined
  February 8, 2018

• BUSINESS EA Pharma Launches Rectabul, Boosts Efforts on Humira to Gird for IBD Showdown
  February 7, 2018

• BUSINESS Poxel Eyeing Japan as 1st Market for Its Lead Diabetes Candidate: CEO
  February 6, 2018

• BUSINESS PorMedTec to Support Development Using Disease Model Pigs, Clients Already Include One Major Drug Maker
  February 6, 2018

• REGULATORY Japan’s 1st Herceptin Biosimilar Clears MHLW Panel, Now in Line for March Approval for Gastric Cancer
  February 5, 2018

• INTERVIEW Interview: Pfizer Japan Looks to Offer High Quality Biosimilars with Go-It-Alone Strategy
  February 2, 2018

• ACADEMIA Overseas Meta-Analyses Find Increased Risk of CKD in Patients Who Use PPIs; Japanese Society of Nephrology Plans Study of Japanese Patients
  February 2, 2018

• BUSINESS Astellas Taps EVP Yasukawa as Next CEO
  February 1, 2018

• REGULATORY Drug Makers Looking to Adopt Continuous Manufacturing, Anticipating 30-40% Lower Production Costs: PMDA Official
  January 31, 2018

• ORGANIZATION Japan Could Miss Out on Wave 1 of Drug Development, Re-Do and Do Right on PMP: PhRMA
  January 30, 2018

• BUSINESS Sanofi to Launch Antibody Drug Dupilumab for Atopic Dermatitis this Spring, Sets Up Special Marketing Force for Potential Blockbuster
  January 30, 2018

• BUSINESS New PMP Scheme Will Cause “Pause” before PIII Go/No-Go Decision: Pfizer Japan Head
  January 29, 2018

• REGULATORY IPRP to Hold First Meeting in June in Japan, May Take up Harmonization of Regulations on Regenerative Medicine Products
  January 26, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 150
• 151
• 152
• 153
• 154
• 155
• 156
• 157
• 158
• …
• Next ›
• 最終 »